Total Funding
74
55
Total FundingPost-IPO Equity raised
Growth Score
-16 pts
Heat Score
-26 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
63371
Citius Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapeutic products.
Jaime Bartushak: CFOPast Role: Leonard-Meron Biosciences, Founder
Gary Talarico: Executive Vice President of OperationsPast Role: Leonard-Meron Biosciences, Founder, Partner & Executive Vice President
About the Company
Citius Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapeutic products for large and growing markets.
Citius products offer new and expanded indications for previously approved pharmaceutical products as a means to achieve market position or market exclusivity. By using previously approved drugs with
substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development.
Citius is advancing two proprietary product candidates, our Mino-Lok™ product and a Hydrocortisone-Lidocaine formulation. Citius believes the markets for its products are large and underserved by the current standard of care.
